PAREXEL International

Survey reveals top concerns in biopharmas achieving commercial success

Friday, March 16, 2012 01:53 PM

Parexel Consulting, a global consultancy service and subsidiary of Parexel International, has released results from a survey polling biopharmaceutical industry professionals, finding that 75% feel the top concern about achieving commercial success is establishing a product price that is reimbursed and accepted by the market.

More... »


Survey shows significant adoption of web-based RTSM systems by clinical sites

Friday, March 16, 2012 12:41 PM

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, has reported results of its Randomization and Trial Supply Management (RTSM) survey, which tracked the evolving use of interactive voice and web response technologies by investigative sites worldwide.

More... »


Parexel expands global clinical logistics capabilities

Wednesday, February 8, 2012 12:45 PM

Global CRO Parexel International is expanding its global clinical logistics services.

More... »

Parexel and ASAN accelerate Korea-based drug development

Wednesday, February 1, 2012 03:33 PM

CRO Parexel International has joined with ASAN Medical Center (AMC), based in Seoul, Korea, to offer clinical trial sponsors based regionally and internationally access to clinical trial services throughout Asia, with a focus on early phase development.

More... »

Parexel posts revenue increase in second quarter

Tuesday, January 31, 2012 02:23 PM

Boston-based CRO Parexel International posted a 9.5% increase in consolidated service revenue for the second quarter ended Dec. 31, 2011, to $333.2 million, from a year ago.

More... »

Perceptive Informatics garners top ratings

Friday, January 20, 2012 03:06 PM

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, received top marks for its medical imaging services in an independent survey on the medical imaging market conducted by Blue Pyramid Consulting.

More... »

Dr. Andrea Zobel joins Marken

Friday, January 13, 2012 12:07 PM

Marken has named Dr. Andrea Zobel new senior director of clinical trial distribution operations.

More... »

PAREXEL advances early phase research technology

Tuesday, November 22, 2011 11:55 AM
PAREXEL International has enhanced its central nervous system (CNS)
capabilities for clinical development through the implementation of
functional magnetic resonance imaging (fMRI) technology in its Early Phase
units. This advanced imaging scanning measures hemodynamic response, or
change in blood flow, related to neural activity in the brain or spinal
cord. Through this approach, PAREXEL is able to provide sponsors with
improved testing paradigms for cognitive biomarkers and better understand
the impact of compounds earlier in disease progression.

More... »

PAREXEL Academy expands to Singapore

Tuesday, October 11, 2011 01:11 PM

PAREXEL Academy, a provider of education and professional training for the biopharmaceutical industry in the field of clinical research, which is operated by PAREXEL International, has entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the increasing demand for talent in the field of clinical research in the Asia region. This demand is being driven by the growing complexity and globalization of biopharmaceutical research and development.

More... »

Trend shifts away from phase I ‘healthy volunteers’

Monday, May 16, 2011 09:35 AM

Looking to stretch their research dollars beyond phase I safety determination and catch early glimpses of efficacy, sponsors and CROs are pursuing patient populations to provide those first signs, rather than depending on “healthy volunteers” for safety and then launching phase II trials.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs